TSE:ACB Aurora Cannabis (ACB) Stock Price, News & Analysis C$7.89 -0.04 (-0.50%) As of 10/3/2025 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock About Aurora Cannabis Stock (TSE:ACB) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Aurora Cannabis alerts:Sign Up Key Stats Today's RangeC$7.79▼C$8.2450-Day RangeC$5.78▼C$8.6652-Week RangeC$4.95▼C$9.90Volume1.23 million shsAverage Volume592,590 shsMarket CapitalizationC$443.78 millionP/E RatioN/ADividend YieldN/APrice TargetC$8.75Consensus RatingStrong Buy Company Overview Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries. Read More Aurora Cannabis Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks5th Percentile Overall ScoreACB MarketRank™: Aurora Cannabis scored higher than 5% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.9 / 5Analyst RatingStrong Buy Upside PotentialAurora Cannabis has a consensus price target of C$8.75, representing about 10.9% upside from its current price of C$7.89.Amount of Analyst CoverageAurora Cannabis has received no research coverage in the past 90 days.Read more about Aurora Cannabis' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Aurora Cannabis is -23.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Aurora Cannabis is -23.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAurora Cannabis has a P/B Ratio of 0.72. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for ACB. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAurora Cannabis does not currently pay a dividend.Dividend GrowthAurora Cannabis does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for ACB. News and Social Media2.9 / 5News Sentiment0.17 News SentimentAurora Cannabis has a news sentiment score of 0.17. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Aurora Cannabis this week, compared to 1 article on an average week.Search Interest30 people have searched for ACB on MarketBeat in the last 30 days. This is an increase of 173% compared to the previous 30 days.MarketBeat Follows2 people have added Aurora Cannabis to their MarketBeat watchlist in the last 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Aurora Cannabis insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 4.33% of the stock of Aurora Cannabis is held by institutions.Read more about Aurora Cannabis' insider trading history. Receive ACB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aurora Cannabis and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ACB Stock News HeadlinesAurora Cannabis (TSX:ACB): Exploring Valuation After U.S. Signals Possible Shift in CBD and Marijuana PolicyOctober 3 at 9:31 AM | finance.yahoo.comAurora Cannabis: President Trump's Video Changes NothingOctober 1 at 4:27 PM | seekingalpha.comNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 trillion calculations per second. Elon Musk and Nvidia’s Jensen Huang are now teaming up to deploy one million of these chips inside what could become the most advanced AI machine on the planet. But according to James Altucher, the real opportunity isn’t in Tesla or Nvidia. He’s uncovered a little-known company that Musk, Nvidia, and even 98% of the Fortune 500 already rely on to make AI 2.0 possible. Nvidia’s CEO has even called this company “essential” to their expansion.October 4 at 2:00 AM | Paradigm Press (Ad)Aurora Cannabis investing into German manufacturing facilitySeptember 18, 2025 | msn.comAurora Cannabis Inc.: Aurora Announces Investment into German Manufacturing FacilitySeptember 18, 2025 | finanznachrichten.deAurora Cannabis to invest in German facility upgradesSeptember 18, 2025 | msn.comThis BioCannabis Firm Could Explode with Product ApprovalAugust 28, 2025 | ca.finance.yahoo.comTilray Surges 14% After Hours On Trump Cannabis ReclassificationAugust 12, 2025 | benzinga.comSee More Headlines ACB Stock Analysis - Frequently Asked Questions How have ACB shares performed this year? Aurora Cannabis' stock was trading at C$6.11 at the beginning of 2025. Since then, ACB stock has increased by 29.1% and is now trading at C$7.89. How were Aurora Cannabis' earnings last quarter? Aurora Cannabis Inc. (TSE:ACB) posted its earnings results on Wednesday, November, 6th. The company reported $0.05 EPS for the quarter, topping analysts' consensus estimates of ($0.30) by $0.35. Aurora Cannabis had a negative trailing twelve-month return on equity of 8.36% and a negative net margin of 22.55%. How do I buy shares of Aurora Cannabis? Shares of ACB stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Aurora Cannabis own? Based on aggregate information from My MarketBeat watchlists, some other companies that Aurora Cannabis investors own include Canopy Growth (CGC), Canopy Growth (WEED), Aphria (APHA), Meta Platforms (META), NVIDIA (NVDA), Organigram (OGI) and Aurora Cannabis (ACBFF). Company Calendar Last Earnings11/06/2024Today10/04/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolTSE:ACB CIKN/A Webauroramj.com Phone+1-604-3625207FaxN/AEmployees1,073Year FoundedN/APrice Target and Rating Average Price Target for Aurora CannabisC$8.75 High Price TargetC$9.00 Low Price TargetC$8.50 Potential Upside/Downside+10.9%Consensus RatingStrong Buy Rating Score (0-4)4.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)C($0.33) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-C$44.16 million Net Margins-22.55% Pretax MarginN/A Return on Equity-8.36% Return on Assets-1.87% Debt Debt-to-Equity Ratio18.72 Current Ratio3.42 Quick Ratio2.48 Sales & Book Value Annual SalesC$357.88 million Price / Sales1.24 Cash FlowC$6.33 per share Price / Cash Flow1.25 Book ValueC$11.03 per share Price / Book0.72Miscellaneous Outstanding Shares56,246,000Free FloatN/AMarket CapC$443.78 million OptionableNot Optionable Beta1.20 (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report This page (TSE:ACB) was last updated on 10/4/2025 by MarketBeat.com Staff From Our PartnersNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredMiss This IRS Strategy Now, Regret It LaterWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredIs $1M Enough to Retire Comfortably in 2025?Many people hope to retire with $1 million in savings, but how long will it really last? The answer can...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aurora Cannabis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aurora Cannabis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.